Dapagliflozin therapy for type 2 diabetes in primary care: changes in HbA1c, weight and blood pressure over 2 years follow-up

J. Wilding*, C. Bailey, U. Rigney, B. Blak, M. Kok, C. Emmas

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

Fingerprint

Dive into the research topics of 'Dapagliflozin therapy for type 2 diabetes in primary care: changes in HbA1c, weight and blood pressure over 2 years follow-up'. Together they form a unique fingerprint.

Medicine & Life Sciences